ArticleActa pharmacologica Sinica2022

Okicamelliaside targets the N-terminal chaperone pocket of HSP90 disrupts the chaperone protein interaction of HSP90-CDC37 and exerts antitumor activity.

Chuan-Jing Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.